Skip to main content
Submitted by Dr S. Patel on 12 January 2019
Image: Fingers pointing at a Bone Scan Image

What is a Bone Scan? What do the results of the scan indicate? When do you need a Bone Scan? How often should you get a Bone Scan? We give you information that will help you discuss your options with your doctor.

What is a Bone Scan 

A Bone scan is done to check the bone mineral density (BMD) so as to assess strength of the bones and probability of any fractures. The scan helps identify any mild (osteopenia) or serious bone loss (osteoporosis). The most common bone density test is the DEXA scan. Here, the entire body is scanned after a tiny amount of radioactive substance called a tracer is injected into a vein. Since the DEXA test scans the entire body, it is able to detect and diagnose a wide range of bone disorders.

Since the bone scan is a nuclear medicine test, excessive exposure to tracers is not recommended. Although, some doctors may argue that the amount of radiation exposure is minute and hence not harmful. The bone scan generally has no side-effects and follow-up care is not required. Any radioactivity from the tracers used get eliminated within two days post the scan.

So who should get a DEXA scan:

  • Women above the age of 65
  • Men above the age of 70

If you are younger than the above age group, your doctor may suggest it if you have the following risk factors:

  • Early menopause or late-onset of menstrual periods.
  • You smoke or drink heavily
  • You have a history of rheumatoid arthritis
  • You have a parent who had hip or other fractures
  • You have low body weight or small body frame
  • Take medications that cause bone loss such as steroids, anti-seizure drugs etc.
  • You have been on cancer treatment like hormonal treatment, chemotherapy
  • Have low estrogen levels
  • Have hyperparathyroidism
  • Have hyperthyroidism
  • Have chronic Vitamin D deficiency.

Let’s look at some other instances when a bone scan is required:

  • If a patient complains of unexplained skeletal pain.
  • Fractures from minor accidents.
  • History of corticosteroid use for more than 3 months.
  • Paget’s disease of bone.
  • Suspicion of a bone infection or bone disease that is unclear on a regular X-ray.
  • To find any cancer originating from the bone
  • To check for metastasis (spread of cancer) in the bones from other areas.
  • To monitor progress of treatment for Bone Cancer.

What do the DEXA Test results mean:

A Radiologist will look for abnormal bone shadows on the images. Dark areas which take up more tracer are termed “hot spots” and light ones with less tracer are the “cold spots”. Areas of fast bone growth, cancer, infections, trauma or repair show up as dark spots (figure b).

The scan also compares the patient’s bone mineral density values (T-score) to those of a young 30 year old normal adult (Z-score). The image below shows what your T-score result means.

How often should you get a bone scan?

There is no fixed interval for scanning of bone density. If your bones are healthy, your doctor may suggest a scan after 15 years. This comes from a 2012 study that reported that bone loss in average women above 65 is quite slow i.e. a woman with normal bone density only loses 5% of bone density in 10 years. Women who show low or moderate density in the initial scan are likely to be more osteoporotic. For such women, testing is recommended every 5 to 1 year depending on their T-score. Best to follow your doctor’s recommendations on when to get a scan depending on your risk factors and medical history.

Updated for cancer treatment on 12th January 2019

Changed
Sat, 01/12/2019 - 15:13

Stories

  • Novel Immunotherapy Vaccine Decreases Recurrence in HER2 Breast Cancer Patients
    Women with breast cancer tumors that overexpress human epidermal growth factor receptor 2 (HER2) may benefit from a novel vaccine to prevent recurrence A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. One of only a few vaccines of its kind in development, GP2 has been shown to be safe and effective for breast cancer patients, reducing recurrence rates by 57%. Further, women with the highest overexpression…
  • My cancer doesn't define who I am
    "I was originally diagnosed with locally advanced cancer, so that means it's advanced within in the chest. Mine was triple negative. It's the most aggressive form of cancer," she said. Her breast cancer diagnosis came in 2008. She found out about her metastatic breast cancer in January 2011, at 33 years old. "Two and half years after my original diagnosis, I found another lump," she said as she held back tears. "It varies from person to person. But my experience has been a bit of a roller…
  • Joan Lunden talks about her Breast Cancer
    How she shared the information with her kids and why - http://www.today.com/health/joan-lunden-how-i-told-my-kids-i-have-cancer-2D80186889 The choices she made in terms of treatment - http://www.people.com/article/joan-lunden-chemotherapy-cancer
  • Daily exercise may help suppress inflammation in rheumatic disease
    Exercise has been shown to transiently suppress inflammation in an animal model of rheumatic disease, bolstering evidence to support the theory that regular physical activity is beneficial for patients with the disease. “Exercise can be a very potent therapeutic intervention to control inflammatory diseases, but unfortunately today it is underutilized in clinical practice,” said study author Dr. Nicholas Young from The Ohio State University Wexner Medical Center, Columbus, Ohio, US. “[In our…
  • Did you know that womb cancer is the fourth most common cancer in women ?
    My cancer could have been caught earlier if I had been alerted about spotting between periods, heavy periods and watery blood between periods as the main symptoms of womb cancer,” she says. But when she asked NHS Choices whether there should be mention of womb cancer on the menopause pages, she received the following reply: “The problem with adding a warning about womb cancer to the menopause pages is that it may cause unnecessary panic.” And this, says Widschwendter, is the nub of the problem…
  • U.S. FDA Approves New Indication for the Use of Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
    The FDA initially approved XTANDI, an oral, once-daily androgen receptor inhibitor, in August 2012 for use in patients with metastatic CRPC who previously received docetaxel (chemotherapy). The new indication approves XTANDI for use in men with metastatic CRPC who have not received chemotherapy. Metastatic CRPC is defined as a cancer that has spread beyond the prostate gland and has progressed despite treatment to lower testosterone (i.e., with a gonadotropin-releasing hormone (GnRH) therapy or…
  • Walking to Help Knee OA: How Much Is Enough?
    Researchers find 6,000 steps per day is the “magic” number for preventing activity limitations in people with knee osteoarthritis (OA), according to a new study published recently online in Arthritis Care & Research. If you have not been doing much walking, start with 3000 steps and then move up to 6000 steps per day http://www.arthritistoday.org/news/walking-protects-against-limitations-348.php
  • Heal Your Cancer
    Don’t fight cancer, heal it by attending to body, mind and spirit, says surgical oncologist Dr Vishal Rao. A child developing from an embryo in a mother’s womb is, in reality, a set of rapidly multiplying cells. But they are controlled and regulated. So, we choose to ‘love’ those cells. But when another set of cells multiply rapidly within our body, albeit haphazardly, we call it ‘Cancerous’! These cells are not foreign cells that have made an appearance from outside,…
  • “I was open to anything, just trying to find things to help me stay alive,” said Geoffrey Boycott
    Geoffrey Boycott describes how counting off his radiotherapy sessions like runs in cricket and Feng Shui helped him survive cancer http://www.telegraph.co.uk/sport/cricket/11080199/Geoffrey-Boycott-reve…
  • FDA approves first non-invasive home based DNA screening test for colorectal cancer
    The U.S. Food and Drug Administration approved Cologuard, the first stool-based colorectal screening test that detects the presence of red blood cells and DNA mutations that may indicate the presence of certain kinds of abnormal growths that may be cancers such as colon cancer or precursors to cancer. Cologuard offers people 50 and older at average risk for colorectal cancer an easy-to-use screening test they can do in the privacy of their own home. Colorectal cancer was the third most…